MYGN
Myriad Genetics Inc
Price:  
25.01 
USD
Volume:  
770,921.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN WACC - Weighted Average Cost of Capital

The WACC of Myriad Genetics Inc (MYGN) is 8.7%.

The Cost of Equity of Myriad Genetics Inc (MYGN) is 8.75%.
The Cost of Debt of Myriad Genetics Inc (MYGN) is 7.00%.

Range Selected
Cost of equity 6.80% - 10.70% 8.75%
Tax rate 16.50% - 20.80% 18.65%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.8% - 10.6% 8.7%
WACC

MYGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 10.70%
Tax rate 16.50% 20.80%
Debt/Equity ratio 0.02 0.02
Cost of debt 7.00% 7.00%
After-tax WACC 6.8% 10.6%
Selected WACC 8.7%